SEC Tracker
Get the app

Alkermes ALKS

Alkermes reports stock sale.

David Joseph Gaffin, insider filing for ALKS

Form
4
Filed
Importance
Routine
  1. David Joseph Gaffin sold 2,034 shares on Oct 2, 2026.
  2. Price per share was $41.03.
  3. Gaffin holds 221,388 shares directly.

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Alkermes files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Halozyme Therapeutics HALO public float $4.5B, Jun 30, 2025
  2. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025